abrdn Life Sciences Investors (HQL) Competitors

abrdn Life Sciences Investors logo
$15.42 -2.07 (-11.84%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$15.40 -0.02 (-0.10%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

HQL vs. RVT, ETOR, USA, TOP, and TY

Should you buy abrdn Life Sciences Investors stock or one of its competitors? abrdn Life Sciences Investors's main competitors and comparable companies include Royce Small-Cap Trust (RVT), eToro Group (ETOR), Liberty All-Star Equity Fund (USA), TOP Financial Group (TOP), and Tri Continental (TY). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "capital markets" industry.

How does abrdn Life Sciences Investors compare to Royce Small-Cap Trust?

Royce Small-Cap Trust (NYSE:RVT) and abrdn Life Sciences Investors (NYSE:HQL) are both small-cap finance companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, media sentiment, risk, dividends, analyst recommendations, profitability and earnings.

Royce Small-Cap Trust has a beta of 1.23, suggesting that its share price is 23% more volatile than the broader market. Comparatively, abrdn Life Sciences Investors has a beta of 0.79, suggesting that its share price is 21% less volatile than the broader market.

In the previous week, Royce Small-Cap Trust and Royce Small-Cap Trust both had 1 articles in the media. Royce Small-Cap Trust's average media sentiment score of 0.00 equaled abrdn Life Sciences Investors'average media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Royce Small-Cap Trust
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
abrdn Life Sciences Investors
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

25.6% of Royce Small-Cap Trust shares are owned by institutional investors. Comparatively, 32.2% of abrdn Life Sciences Investors shares are owned by institutional investors. 0.1% of Royce Small-Cap Trust shares are owned by company insiders. Comparatively, 10.1% of abrdn Life Sciences Investors shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Royce Small-Cap Trust pays an annual dividend of $1.48 per share and has a dividend yield of 9.5%. abrdn Life Sciences Investors pays an annual dividend of $2.24 per share and has a dividend yield of 14.5%.

Company Net Margins Return on Equity Return on Assets
Royce Small-Cap TrustN/A N/A N/A
abrdn Life Sciences Investors N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Royce Small-Cap TrustN/AN/AN/AN/AN/A
abrdn Life Sciences InvestorsN/AN/AN/AN/AN/A

Summary

abrdn Life Sciences Investors beats Royce Small-Cap Trust on 3 of the 4 factors compared between the two stocks.

How does abrdn Life Sciences Investors compare to eToro Group?

eToro Group (NASDAQ:ETOR) and abrdn Life Sciences Investors (NYSE:HQL) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, media sentiment, institutional ownership and risk.

32.2% of abrdn Life Sciences Investors shares are owned by institutional investors. 10.1% of abrdn Life Sciences Investors shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, eToro Group had 2 more articles in the media than abrdn Life Sciences Investors. MarketBeat recorded 3 mentions for eToro Group and 1 mentions for abrdn Life Sciences Investors. abrdn Life Sciences Investors' average media sentiment score of 0.00 beat eToro Group's score of -0.10 indicating that abrdn Life Sciences Investors is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
eToro Group
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
abrdn Life Sciences Investors
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

eToro Group has a beta of 1.84, suggesting that its stock price is 84% more volatile than the broader market. Comparatively, abrdn Life Sciences Investors has a beta of 0.79, suggesting that its stock price is 21% less volatile than the broader market.

eToro Group currently has a consensus target price of $40.25, suggesting a potential upside of 116.86%. Given eToro Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe eToro Group is more favorable than abrdn Life Sciences Investors.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
eToro Group
2 Sell rating(s)
4 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.47
abrdn Life Sciences Investors
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

eToro Group has a net margin of 2.34% compared to abrdn Life Sciences Investors' net margin of 0.00%. eToro Group's return on equity of 17.17% beat abrdn Life Sciences Investors' return on equity.

Company Net Margins Return on Equity Return on Assets
eToro Group2.34% 17.17% 13.03%
abrdn Life Sciences Investors N/A N/A N/A

eToro Group has higher revenue and earnings than abrdn Life Sciences Investors.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
eToro Group$13.84B0.11$215.70M$2.278.18
abrdn Life Sciences InvestorsN/AN/AN/AN/AN/A

Summary

eToro Group beats abrdn Life Sciences Investors on 9 of the 12 factors compared between the two stocks.

How does abrdn Life Sciences Investors compare to Liberty All-Star Equity Fund?

abrdn Life Sciences Investors (NYSE:HQL) and Liberty All-Star Equity Fund (NYSE:USA) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.

Company Net Margins Return on Equity Return on Assets
abrdn Life Sciences InvestorsN/A N/A N/A
Liberty All-Star Equity Fund N/A N/A N/A

abrdn Life Sciences Investors pays an annual dividend of $2.24 per share and has a dividend yield of 14.5%. Liberty All-Star Equity Fund pays an annual dividend of $0.67 per share and has a dividend yield of 12.4%.

In the previous week, Liberty All-Star Equity Fund had 1 more articles in the media than abrdn Life Sciences Investors. MarketBeat recorded 2 mentions for Liberty All-Star Equity Fund and 1 mentions for abrdn Life Sciences Investors. Liberty All-Star Equity Fund's average media sentiment score of 0.50 beat abrdn Life Sciences Investors' score of 0.00 indicating that Liberty All-Star Equity Fund is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
abrdn Life Sciences Investors
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Liberty All-Star Equity Fund
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

abrdn Life Sciences Investors has a beta of 0.79, indicating that its share price is 21% less volatile than the broader market. Comparatively, Liberty All-Star Equity Fund has a beta of 1.08, indicating that its share price is 8% more volatile than the broader market.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
abrdn Life Sciences InvestorsN/AN/AN/AN/AN/A
Liberty All-Star Equity FundN/AN/AN/AN/AN/A

32.2% of abrdn Life Sciences Investors shares are held by institutional investors. Comparatively, 10.0% of Liberty All-Star Equity Fund shares are held by institutional investors. 10.1% of abrdn Life Sciences Investors shares are held by company insiders. Comparatively, 0.1% of Liberty All-Star Equity Fund shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

abrdn Life Sciences Investors and Liberty All-Star Equity Fund tied by winning 3 of the 6 factors compared between the two stocks.

How does abrdn Life Sciences Investors compare to TOP Financial Group?

TOP Financial Group (NASDAQ:TOP) and abrdn Life Sciences Investors (NYSE:HQL) are both small-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their risk, media sentiment, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Company Net Margins Return on Equity Return on Assets
TOP Financial GroupN/A N/A N/A
abrdn Life Sciences Investors N/A N/A N/A

abrdn Life Sciences Investors has lower revenue, but higher earnings than TOP Financial Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TOP Financial Group$4.72M405.10-$1.17M-$0.02N/A
abrdn Life Sciences InvestorsN/AN/AN/AN/AN/A

In the previous week, TOP Financial Group had 3 more articles in the media than abrdn Life Sciences Investors. MarketBeat recorded 4 mentions for TOP Financial Group and 1 mentions for abrdn Life Sciences Investors. TOP Financial Group's average media sentiment score of 1.08 beat abrdn Life Sciences Investors' score of 0.00 indicating that TOP Financial Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TOP Financial Group
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
abrdn Life Sciences Investors
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

0.3% of TOP Financial Group shares are held by institutional investors. Comparatively, 32.2% of abrdn Life Sciences Investors shares are held by institutional investors. 85.6% of TOP Financial Group shares are held by insiders. Comparatively, 10.1% of abrdn Life Sciences Investors shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

TOP Financial Group has a beta of -0.82, indicating that its share price is 182% less volatile than the broader market. Comparatively, abrdn Life Sciences Investors has a beta of 0.79, indicating that its share price is 21% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TOP Financial Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
abrdn Life Sciences Investors
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

TOP Financial Group beats abrdn Life Sciences Investors on 5 of the 7 factors compared between the two stocks.

How does abrdn Life Sciences Investors compare to Tri Continental?

abrdn Life Sciences Investors (NYSE:HQL) and Tri Continental (NYSE:TY) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, risk, profitability, media sentiment, analyst recommendations, institutional ownership and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
abrdn Life Sciences InvestorsN/AN/AN/AN/AN/A
Tri ContinentalN/AN/AN/AN/AN/A

In the previous week, abrdn Life Sciences Investors and abrdn Life Sciences Investors both had 1 articles in the media. Tri Continental's average media sentiment score of 1.00 beat abrdn Life Sciences Investors' score of 0.00 indicating that Tri Continental is being referred to more favorably in the news media.

Company Overall Sentiment
abrdn Life Sciences Investors Neutral
Tri Continental Positive

abrdn Life Sciences Investors pays an annual dividend of $2.24 per share and has a dividend yield of 14.5%. Tri Continental pays an annual dividend of $1.14 per share and has a dividend yield of 3.6%.

32.2% of abrdn Life Sciences Investors shares are owned by institutional investors. Comparatively, 10.2% of Tri Continental shares are owned by institutional investors. 10.1% of abrdn Life Sciences Investors shares are owned by company insiders. Comparatively, 8.7% of Tri Continental shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

abrdn Life Sciences Investors has a beta of 0.79, meaning that its share price is 21% less volatile than the broader market. Comparatively, Tri Continental has a beta of 0.84, meaning that its share price is 16% less volatile than the broader market.

Company Net Margins Return on Equity Return on Assets
abrdn Life Sciences InvestorsN/A N/A N/A
Tri Continental N/A N/A N/A

Summary

abrdn Life Sciences Investors beats Tri Continental on 3 of the 5 factors compared between the two stocks.

Get abrdn Life Sciences Investors News Delivered to You Automatically

Sign up to receive the latest news and ratings for HQL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HQL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HQL vs. The Competition

Metricabrdn Life Sciences InvestorsCapital Markets IndustryFinance SectorNYSE Exchange
Market Cap$467.68M$4.27B$12.12B$20.35B
Dividend Yield14.56%5.67%5.05%3.95%
P/E RatioN/A23.3219.4427.91
Price / SalesN/A8.405.343.50
Price / CashN/A29.1519.7214.62
Price / BookN/A1.671.713.40
Net IncomeN/A$419.50M$1.32B$1.07B
7 Day Performance-15.48%-4.23%-4.23%-7.13%
1 Month Performance-14.06%-4.26%-4.45%-7.56%
1 Year Performance-8.38%-4.18%2.12%0.53%

abrdn Life Sciences Investors Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HQL
abrdn Life Sciences Investors
N/A$15.42
-11.8%
N/A-8.4%$467.68MN/AN/AN/A
RVT
Royce Small-Cap Trust
N/A$17.27
+0.6%
N/A+1.6%$2.15B$88.69MN/A50
ETOR
eToro Group
4.6151 of 5 stars
$22.90
+6.2%
$42.50
+85.6%
-49.6%$1.89B$13.84B8.591,520
USA
Liberty All-Star Equity Fund
N/A$6.10
+0.7%
N/A-8.6%$1.88BN/AN/AN/A
TOP
TOP Financial Group
0.4513 of 5 stars
$15.25
+3.8%
N/A+193.6%$1.87B$4.72MN/A30

Related Companies and Tools


This page (NYSE:HQL) was last updated on 11/22/2026 by MarketBeat.com Staff.
From Our Partners